ID: ALA5282294

Max Phase: Preclinical

Molecular Formula: C17H16N2O

Molecular Weight: 264.33

Associated Items:

Representations

Canonical SMILES:  Cc1[nH]c2ccccc2c1C1Nc2ccccc2CO1

Standard InChI:  InChI=1S/C17H16N2O/c1-11-16(13-7-3-5-9-15(13)18-11)17-19-14-8-4-2-6-12(14)10-20-17/h2-9,17-19H,10H2,1H3

Standard InChI Key:  YOUQDMMVNFUQNX-UHFFFAOYSA-N

Associated Targets(Human)

Alpha glucosidase 860 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 264.33Molecular Weight (Monoisotopic): 264.1263AlogP: 4.12#Rotatable Bonds: 1
Polar Surface Area: 37.05Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.88CX Basic pKa: CX LogP: 3.50CX LogD: 3.50
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.69Np Likeness Score: -0.20

References

1. Zhu Y, Zhao J, Luo L, Gao Y, Bao H, Li P, Zhang H..  (2021)  Research progress of indole compounds with potential antidiabetic activity.,  223  [PMID:34192642] [10.1016/j.ejmech.2021.113665]

Source